US approves 1st drug developed to prevent chronic migraines

link to post

By Linda A. Johnson Associated Press  May 18, 2018

TRENTON, N.J. (AP) — U.S. regulators Thursday approved the first drug designed to prevent chronic migraines.

The Food and Drug Administration’s action clears the monthly shot Aimovig (AIM’-oh-vig) for sale. It’s the first in a new class of long-acting drugs

Continue reading...

Leave a Reply